Derek Poon  > Baker McKenzie > Hong Kong, Hong Kong > Lawyer Profile

Baker McKenzie
14TH FLOOR, One Taikoo Place
979 King’s Road
Quarry Bay
Hong Kong

Work Department

Transactional - Private Equity

Position

Partner

Career

Derek Poon is a partner in Baker McKenzie’s Hong Kong office and a member of the Firm’s Private Equity and Mergers & Acquisitions practice groups. He is also the chair of Baker McKenzie’s Asia Pacific Private Equity Group and a member of the Global Private Equity Steering Committee.

Derek has extensive experience representing private equity firms, investment banks and major corporations on a wide variety of corporate matters, including public and private mergers and acquisitions, private equity, joint ventures, real estate private equity and distressed M&A transactions. Earlier in his career, Derek spent time on client secondment with Bain Capital with the Asia Private Equity team.

Derek is highly recognized in M&A and Private Equity by various legal directories.

Qualified in the US, Hong Kong, UK and Australia, Derek has worked on several significant transactions in Hong Kong, Mainland China, Japan, South Korea, Taiwan, India, Australia, ASEAN countries as well as on outbound deals into Europe and North America.

Languages

Cantonese; English; Mandarin

Lawyer Rankings

Hong Kong > Private equity

(Leading partners)

Derek PoonBaker McKenzie

The ‘very knowledgeableDerek Poon leads the ‘well-rounded‘ team at Baker McKenzie, which leverages its relationship with Fenxun to handle the full range of private equity issues. Poon is recommended for his vast knowledge of distressed M&A, while Xinxing Chen is noted for advising on LBOs and deals involving Chinese companies. Robert Wright is a key name for leveraged M&A transactions, co-investment mandates, and exits. Vivian Choi routinely assists both Chinese and international corporate and private equity clients with strategic investments and joint ventures.

Hong Kong > Corporate (including M&A)

Baker McKenzie houses an ‘unparalleled‘ team which often draws on the strength of its relationship with Baker McKenzie FenXun to assist global corporations looking to invest in Hong Kong and China. Practice head Tracy Wut has vast experience in advising on foreign direct investments and transactions within the healthcare and pharmaceutical industries. In addition to leading the capital markets group, the ‘extremely professional and reliableChristina Lee has deep knowledge of corporate finance issues and corporate regulatory matters. Derek Poon is a key name on the private equity side, often advising on both public, private, and distressed M&A., while the ‘exceptionalRobert Wright routinely assists clients with co-investments and leveraged M&A.

China > Life sciences and healthcare: foreign firms

Baker McKenzie FenXun‘s Greater China healthcare and life sciences group comprises lawyers who are medical practitioners, as well as lawyers who hold PhDs in molecular biology, biotechnology, pharmacology and bioethics. The practice, which additionally fields non-lawyer medical experts, acts for large pharmaceutical, medical device, healthcare and life sciences companies on both inbound and outbound work, including transactional, regulatory and compliance matters. At the firm’s joint operation partner, FenXun Partners, Vivian Wu leads the firm’s investigations, compliance and ethics team in Beijing, where Yilan Yang specialises in the healthcare and cosmetics sectors. Over in Hong Kong, Isabella LiuDerek PoonGrace Tso and Mini vandePol are the names to note.

China > Private equity: foreign firms

Baker McKenzie FenXun routinely leverages its enviable global footprint for major cross-border investment and divestment transactions. The practice has notable sector experience in healthcare, life sciences, TMT, digital infrastructure, consumer, retail and real estate. In Shanghai, China private equity head Hong Zhang is experienced in advising Chinese companies and multinationals on both China inbound and outbound investments. Over in Hong Kong, Derek Poon advises private equity firms, investment banks and major corporations on a range of corporate matters.